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Induced pluripotent stem (iPS) cells differentiated into
neural progenitor cells (NPCs) hold great potential as a tool
for modeling brain disease. When coupled to high content
screening (HCS), NPCs may become a powerful tool for
drug discovery. One of the goals of the new Molecular Biol-
ogy and Cell Reprogramming, headed by Dr. Stevens Rehen
at the D’Or Institute for Research and Education, is to
develop a high content screening (HCS) strategy to study
human brain diseases through the use of iPS. As a starting
point, the effects of psychoactive drugs were characterized
in NPCs by using HCS. Thousands of cells and single mito-
chondria were analyzed individually by HCS software and
submitted to several sequences of morphometric analyses
and fluorescence quantification. Morphological and func-
tional alterations in mitochondria, which can be linked to
energetic metabolism failure, a key trigger to abnormal neu-
ronal development, were also observed. I will discuss the
impact of HCS technology applied to neural stem cells as
an attractive platform to drug discovery, cytotoxicity assess-
ment and disease modeling.
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